Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Komarom – page 13

276 clinical trials in Komarom, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Komarom at a glance
276
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

276 trials in Komarom

Open in trial search

Atrial fibrillation

Not recruiting

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:HungaryHungary
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Astegolimab
  • Sponsor:F. Hoffmann-La Roche AG

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Crohn's disease

Not recruiting

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Astrazeneca AB

Hodgkin's disease

Not recruiting

Study Comparing Brentuximab Vedotin with Drug Combination for Treating Advanced Classical Hodgkin Lymphoma in Patients

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin
  • Sponsor:Takeda Development Center Americas Inc.

B-cell lymphoma+1

Not recruiting

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Genmab A/S

Schizophrenia

Not recruiting

Long-term Safety Study of Emraclidine for Adults with Schizophrenia

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Emraclidine
  • Sponsor:Cerevel Therapeutics LLC

Crohn's disease

Not recruiting

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Bladder cancer

Not recruiting

Study on the Effectiveness of Durvalumab, Tremelimumab, and Chemotherapy in Patients with Advanced Bladder or Urinary System Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Astrazeneca AB

A study to evaluate the effects of obicetrapib and ezetimibe on cholesterol levels in adults with type 2 diabetes or metabolic syndrome

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ezetimibe
  • Sponsor:NewAmsterdam Pharma B.V.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Komarom

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on atherosclerotic cardiovascular disease prevention and innovative treatments for atrial fibrillation. Research aims to evaluate new therapeutic approaches for stroke prevention and cardiac event reduction.

  • Stroke Prevention Therapies
  • Cardiovascular Event Management
  • Blood Clot Prevention

Multiple trials comparing the effectiveness of novel medications against established treatments for heart conditions.

02 Metabolic Disorders

Clinical research examining treatments for Type 2 Diabetes Mellitus and mixed dyslipidemia. Studies evaluate new therapeutic agents aimed at improving metabolic health outcomes.

  • Diabetes Management
  • Lipid Disorders
  • Cardiovascular Risk Reduction

Innovative approaches being tested to address complex metabolic conditions and their complications.

03 Respiratory Medicine

Advanced research into treating Chronic Obstructive Pulmonary Disease, particularly focusing on patients with frequent exacerbations. Studies evaluate targeted biological therapies for respiratory conditions.

  • COPD Management
  • Exacerbation Prevention
  • Respiratory Function Improvement

Trials specifically designed to address severe respiratory conditions and improve patient outcomes.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.